Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by IVERIC bio, Inc.

< Previous 1 2 Next >
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
From IVERIC Bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual Meeting
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present at the Cowen 43rd Annual Health Care Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on Wednesday, March 1, 2023
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy
From Iveric bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Proposed Offering of Common Stock
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Submission of First Part of NDA for Rolling Review of Avacincaptad Pegol for the Treatment of Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present at Upcoming Investor Conferences
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.